Nikhil C Munshi

Title: Nikhil C Munshi: Innovator in Cancer Treatment

Introduction

Nikhil C Munshi is a prominent inventor based in Needham, MA (US), known for his significant contributions to cancer treatment through innovative research. He holds a total of five patents that focus on advancing therapeutic strategies in oncology.

Latest Patents

Among his latest patents, one includes T cell receptors specific to B-cell maturation antigen for the treatment of cancer. This disclosure relates to T cell receptors, which comprise alpha chains and beta chains, that are specific to B-cell maturation antigen (BCMA). It also covers T cells comprising these receptors and methods of use thereof. Another notable patent involves immunogenic peptides specific to BCMA and TACI antigens. This disclosure pertains to immunogenic peptides that are specific to B-cell maturation antigen (BCMA) and Transmembrane activator and CAML interactor (TACI), along with methods of use thereof.

Career Highlights

Nikhil C Munshi is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to push the boundaries of cancer research and treatment. His work has been instrumental in developing new therapeutic approaches that target specific antigens associated with cancer.

Collaborations

He collaborates with esteemed colleagues, including Jooeun Bae and Kenneth Carl Anderson, to further enhance the impact of his research in the field of oncology.

Conclusion

Nikhil C Munshi's innovative work and patents are paving the way for new cancer treatments, showcasing his dedication to improving patient outcomes. His contributions to the field are invaluable and continue to inspire future research in cancer therapy.